Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling
Seeking Alpha
Wed, 07/14/10 - 10:35 am
obesity
Qnexa
FDA
Vivus
Contrave
Orexigen
Arena Pharmaceuticals
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tue, 07/13/10 - 11:14 am
obsesity
diet drugs
advisory panels
FDA
Qnexa
Vivus
Arena Pharmaceuticals
Contrave
Orexigen
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tue, 07/13/10 - 08:43 am
FDA
diet drugs
obesity
Vivus
advisory panels
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Mon, 07/12/10 - 02:39 pm
FDA
Vivus
obesity
Qnexa
Orexigen
Arena Pharmaceuticals
Contrave
Biotech Stock Mailbag: Somaxon
TheStreet.com
Fri, 07/9/10 - 12:27 pm
Somaxon
Dendreon
Arena Pharmaceuticals
Orexigen
Vivus
Roche
GSK
Immunogen
How to Trade on an FDA Advisory Panel
Minyanville
Fri, 07/9/10 - 11:38 am
FDA
advisory panels
Qnexa
Arena Pharmaceuticals
Vivus
Orexigen
Arena, Orexigen Race for a Fat Opportunity
Seeking Alpha
Tue, 07/6/10 - 10:43 am
obesity
Arena Pharmaceuticals
Orexigen
Contrave
Eisai
Will Prescription Diet Pills Become Hot - Again?
Pharmalot
Thu, 07/1/10 - 05:23 pm
diet drugs
obesity
Arena Pharmaceuticals
Eisai
Contrave
Orexigen
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
diabetes
Orexigen
Contrave
Avandia
GSK
Merck
Eli Lilly
Amylin
Novo Nordisk
JNJ
MannKind
Afrezza
Orexigen says obesity drug treated depression
Yahoo/AP
Mon, 06/28/10 - 02:55 pm
Orexigen
obesity
depression
Contrave
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Sat, 06/26/10 - 09:17 am
obesity
Orexigen
Qnexa
Vivus
Abbott Laboratories
GSK
Meridia
Alli
Orexigen says FDA sets Jan. 31 date for Contrave
Yahoo/AP
Thu, 06/17/10 - 11:03 pm
FDA
Contrave
Orexigen
obesity
What Investors Think About Orexigen Therapeutics
Motley Fool
Wed, 06/9/10 - 08:15 am
investors
Orexigen
Orexigen revises obesity drug data; shares fall
Reuters
Wed, 04/14/10 - 10:44 am
obesity
Orexigen
Contrave
Xoma rallies on patents; Orexigen slides
Marketwatch
Tue, 04/13/10 - 10:46 am
Xoma
Orexigen
patents
Contrave
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
obesity
Vivus
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Orexigen
FDA
obesity
Contrave
Vivus
Arena Pharmaceuticals
Qnexa
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Qnexa
lorcaserin
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 11:14 am
FDA
Cadence Pharmaceuticals
Acorda Therapeutics
Auxilium
Gilead Sciences
Shire
Amylin
Cell Therapeutics
Dendreon
InterMune
Amgen
Human Genome
NicOx
Vivus
Arena Pharmaceuticals
Orexigen
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »